News
Urenco – Board Developments
13 May 2015
Helmut Engelbrecht, Chief Executive Officer (CEO) of Urenco Ltd has announced that he plans to retire during this financial year. The Board of Urenco Ltd has initiated the search for a new CEO. Helmut will continue as CEO until his successor is appointed and will work with the Board to ensure a smooth transition.
Helmut has led the company since 2006 and overseen a three fold increase in its capacity and the development, from conception to commissioning, of the only civil nuclear uranium enrichment facility in the USA. Urenco now supplies over 30% of the global enrichment market and has achieved annual EBITDA in excess of €1 billion.
The Board extends its thanks to Helmut for his significant contribution to Urenco.
Sir John Hood reached the end of his three year term as Chairman of the Board of Urenco Ltd in December 2014 and had advised the Board of his intention to retire. At the request of the Board, he kindly agreed to remain as Chairman for orderly succession.
The Board thanks John for his continuing contribution to the governance of the company.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries
See what we've been up to recently on our social media channels
